Silverback Therapeutics I... (SBTX)

NASDAQ: SBTX · Real-Time Price · USD

5.87

0.06 (1.03%)

At close: Nov 09, 2022, 5:00 AM

Silverback Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	60.53M	119.02M	87.86M	210.52M	203.22M	218.69M	233.99M	254.04M	300.66M	359.69M	374.2M	386.57M	142.32M	9.98M
Short-Term Investments	181.37M	133.19M	176.69M	63.86M	63.4M	39.28M	19.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	24.22M	43.97M	64.78M	39.94M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.17M	2.77M	2.86M	2.96M	250K	250K	250K	250K	350K	350K	350K	350K	1.57M	550K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.56M	2.83M	2.8M	3.32M	4.17M	5.15M	7.49M	7.45M	4.7M	3.34M	4.14M	4.09M	865K	552K
Total Current Assets	244.47M	255.03M	267.35M	277.7M	270.8M	263.13M	261.33M	261.49M	305.36M	363.03M	378.35M	390.66M	143.18M	10.53M
Property-Plant & Equipment	917K	943K	982K	774K	15K	6.4M	6.91M	6.95M	6.92M	3.6M	3.5M	3.8M	4.16M	4.57M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.09M	3.72M	3.84M	3.73M	265K	30.87M	51.14M	71.97M	47.21M	3.95M	3.85M	4.15M	5.73M	5.12M
Total Assets	248.56M	258.75M	271.19M	281.44M	271.06M	294M	312.47M	333.47M	352.56M	366.98M	382.2M	394.8M	148.91M	15.65M
Account Payables	n/a	n/a	n/a	n/a	126K	2.11M	2.63M	2.08M	1.72M	1.8M	4.37M	2.58M	2.16M	3.52M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	235K	233K	232K	230K	215K	881K	1.12M	1.09M	1.09M	958K	1.42M	844K	1.07M	11.51M
Other Current Liabilities	10.95M	9.82M	9.61M	5.21M	3.65M	8.15M	11.05M	11.73M	12.54M	12.79M	5.8M	6.17M	4.77M	2.9M
Total Current Liabilities	11.18M	10.05M	9.84M	5.44M	3.99M	11.14M	14.81M	14.89M	15.35M	15.55M	11.6M	9.6M	8.01M	17.93M
Long-Term Debt	92K	146K	199K	251K	n/a	4.07M	4.43M	4.76M	5.08M	1.78M	2.06M	2.33M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	2.85M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	219.16M	56.5M
Total Long-Term Liabilities	92K	146K	199K	3.1M	341K	4.07M	4.43M	4.76M	5.08M	1.78M	2.06M	2.33M	219.16M	56.5M
Total Liabilities	11.27M	10.2M	10.04M	8.55M	3.99M	15.21M	19.24M	19.65M	20.43M	17.33M	13.65M	11.93M	227.16M	74.42M
Total Debt	327K	379K	431K	481K	215K	4.95M	5.55M	5.85M	6.17M	2.74M	3.48M	4.07M	4.53M	15.62M
Common Stock	9K	9K	9K	9K	4K	4K	4K	4K	4K	4K	3K	3K	n/a	n/a
Retained Earnings	-124.14M	-109.27M	-91.9M	-76.94M	-248.14M	-230.27M	-210.84M	-186.21M	-162.75M	-140.1M	-115.6M	-96.73M	-83.65M	-63.79M
Comprehensive Income	-161K	-180K	n/a	n/a	-1.62M	-1.55M	-1.25M	-326K	-34K	n/a	n/a	-2.05M	n/a	-1.45M
Shareholders Equity	237.28M	248.55M	261.15M	272.89M	267.07M	278.79M	293.23M	313.81M	332.13M	349.65M	368.55M	382.88M	-78.25M	-58.78M
Total Investments	181.37M	133.19M	176.69M	63.86M	63.4M	63.5M	63.83M	64.78M	39.94M	n/a	n/a	n/a	n/a	n/a